Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

NCT00460603 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: bevacizumab
DRUG: AG-013726
DRUG: AG-013736 (axitinib)

Sponsor

Pfizer